Rec-Biotechnology
Dedicated to the R&D, production and commercialization of innovative vaccines, leveraging its core technology platforms.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.0b (Public information from Jun 2021)
Taizhou Zhejiang (HQ)
Authorizing premium user...